solomo.ai
Star Portfolios

Clarus Capital I

Institution · data to Jun 2026

Disclosed value

₹1,672 Cr

Jun 2026 closes

At current prices

…

Current holdings

12

Tracked since

Sep 2023

Portfolio value over time

Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.

Current holdings (Jun 2026)

+1.15pp₹223 Cr
+0.21pp₹214 Cr
+0.71pp₹196 Cr
NEW₹188 Cr
0.00pp₹157 Cr
+0.42pp₹142 Cr
-0.27pp₹134 Cr
-0.18pp₹107 Cr
+0.06pp₹105 Cr
-0.47pp₹81 Cr
+0.13pp₹66 Cr
-0.90pp₹58 Cr

Portfolio Summary

Jun 2026

As of Jun 2026, Clarus Capital I — an institution tracked through public shareholding filings — disclosed 12 holdings in Indian listed companies worth ₹1,672 crore. The same holdings-at-filing-value basis put it at ₹1,195 crore in Mar 2026 (+39.9%). Solomo carries these filings back to Sep 2023.

Largest disclosed positions in Jun 2026: RPG Life Sciences Ltd (RPGLIFE — 5.59% of the company, ₹223 crore); Akums Drugs & Pharmaceuticals Ltd (AKUMS — 2.17% of the company, ₹214 crore); Innova Captab Ltd (INNOVACAP — 3.58% of the company, ₹196 crore); Bliss GVS Pharma Ltd (BLISSGVS — 3.51% of the company, ₹188 crore); Hindustan Foods Ltd (HNDFDS — 2.34% of the company, ₹157 crore). Those 5 account for 58% of the disclosed value.

Changes in the Jun 2026 filings: newly disclosed — Bliss GVS Pharma Ltd. Stake raised in RPG Life Sciences Ltd (+1.15 pp), Innova Captab Ltd (+0.71 pp), Ador Welding Ltd (+0.42 pp). Stake reduced in R Systems International Ltd (−0.90 pp), Advanced Enzyme Technologies Ltd (−0.47 pp), Healthcare Global Enterprises Ltd (−0.27 pp).

Combined disclosed portfolio value by filed quarter, valued at each quarter's closing prices.
QuarterDisclosed valueChange
Jun 2026₹1,672 Cr+39.9%
Mar 2026₹1,195 Cr−9.8%
Dec 2025₹1,325 Cr+27.9%
Sep 2025₹1,036 Cr+20.7%
Jun 2025₹859 Cr+30.7%
Mar 2025₹657 Cr−9.5%
Dec 2024₹726 Cr+11.5%
Sep 2024₹651 Cr+35.4%
All star portfolios 2 further positions appear in earlier filings but not in Jun 2026.Quarterly shareholding filings (BSE/NSE); only stakes above the 1% disclosure threshold are public. Not investment advice.